Nu Wave Investment Management, LLC Vertex Pharmaceuticals Inc Transaction History

Nu Wave Investment Management, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $84,610 - $106,809	-478 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$181.39 - $202.99 $274,805 - $307,529	-1,515 Reduced 76.02%	478 $87,000
Q2 2021 Jul 16, 2021	BUY	$187.49 - $221.1 $120,181 - $141,725	641 Added 47.41%	1,993 $402,000
Q1 2021 Apr 09, 2021	BUY	$207.02 - $241.31 $279,891 - $326,251	1,352 New	1,352 $291,000
Q4 2020 Jan 11, 2021	SELL	$207.01 - $276.09 $4,761 - $6,350	-23 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$255.65 - $303.1 $241,333 - $286,126	-944 Reduced 97.62%	23 $6,000
Q2 2020 Jul 13, 2020	BUY	$225.48 - $295.8 $218,039 - $286,038	967 New	967 $275,000
Q1 2020 Apr 14, 2020	SELL	$199.77 - $247.81 $716,375 - $888,646	-3,586 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$166.71 - $223.91 $582,151 - $781,893	3,492 Added 3714.89%	3,586 $785,000
Q3 2019 Oct 15, 2019	SELL	$166.23 - $187.09 $21,277 - $23,947	-128 Reduced 57.66%	94 $16,000
Q2 2019 Jul 18, 2019	SELL	$164.61 - $190.37 $93,333 - $107,939	-567 Reduced 71.86%	222 $41,000
Q1 2019 Apr 11, 2019	BUY	$163.73 - $194.7 $129,182 - $153,618	789 New	789 $146,000
Q4 2018 Jan 22, 2019	SELL	$151.91 - $192.21 $15,798 - $19,989	-104 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$167.73 - $192.74 $16,773 - $19,274	100 Added 2500.0%	104 $20,000
Q2 2018 Aug 01, 2018	SELL	$145.72 - $169.96 $167,869 - $195,793	-1,152 Reduced 99.65%	4 $1,000
Q1 2018 May 02, 2018	BUY	$151.6 - $177.13 $166,153 - $194,134	1,096 Added 1826.67%	1,156 $184,000
Q4 2017 Feb 07, 2018	BUY	$137.28 - $155.55 $8,236 - $9,333	60	60 $9,000

1,722

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nu Wave Investment Management, LLC with notifications on news.